1. Evaluation of potential predictive biomarker for cetuximab in a panel of colorectal cancer patient-derived xenografts (PDX). (December 2016) Authors: Rivera, M.; Hoffmann, J.; Wulf-Goldenberg, A.; Schlag, P.M.; Merk, J.; Walther, W.; Fichtner, I. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of intratumoral heterogeneity of renal cancer on drug response and development of resistance in patient derived xenografts. (December 2016) Authors: Zeisig, R.; Flechsig, S.; Wulf-Goldenberg, A.; Schmees, C.; Jandrig, B.; Hennenlotter, J.; Bedke, J.; Stenzl, A.; Schostak, M.; Becker, M.; Fichtner, I.; Hoffmann, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S73 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Molecular subtypes of head and neck cancer predict response to cetuximab treatment. (December 2016) Authors: Klinghammer, K.; Otto, R.; Raguse, J.D.; Albers, A.; Fichtner, I.; Keilholz, U.; Hoffmann, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Mouse models for translational preclinical research in immuno-oncology. (December 2016) Authors: Wulf-Goldenberg, A.; Stecklum, M.; Reiner, Z.; Fichtner, I.; Hoffmann, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. New preclinical models for neuro-oncology: Orthotopic patient-derived glioblastoma xenografts in mice. (December 2016) Authors: Orthmann, A.; Haybäck, J.; Jödicke, A.; Kuhn, S.; Linnebacher, M.; Fichtner, I.; Hoffmann, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Patient-derived xenografts (PDX) from agressive haematological malignancies. (December 2016) Authors: Brzezicha, B.; Siegert, A.; Walther, W.; Fichtner, I.; Hoffmann, J.; Karawajew, L.; Schmitt, C.; Janz, M. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Preclinical models of patient derived xenografts (PDX) for immuno-oncology research. (December 2016) Authors: Stecklum, M.; Wulf-Goldenberg, A.; Brzezicha, B.; Fichtner, I.; Hoffmann, J. Journal: European journal of cancer Issue: Volume 69(2016)supplement 1 Page Start: S59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗